CRO

sold

Fierce Biotech

Charles River sells CDMO and discovery assets in strategic pivot

The CRO is offloading its contract manufacturing operation and some of its European discovery services, which brought in $287 million last year.

Darren Incorvaia Feb 25, 2026 1:54pm

Fierce Biotech

BMS and Evinova pen global development partnership

Feb 9, 2026 2:33pm

Charles River Boston Massachusetts

Fierce Biotech

Charles River to close Maryland CDMO site, lay off 20 staffers

Feb 3, 2026 12:20pm

VanNaarden

Fierce Biotech

Lilly oncology head weighs in on FDA cancer drug policies

Oct 21, 2025 11:53am

Novo

Fierce Biotech

Novo Nordisk vs. KBP: From $1.3B deal to legal battlefield

Oct 2, 2025 3:00am